Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Pillser
Search
Sign UpLog In

Bifidobacterium animalis subsp. lactis Bi-07

Safety profile

3 studies reporting safety data1 increased-risk finding

Bifidobacterium animalis subsp. lactis Bi-07 has been associated with increased risk of nausea in one study (OR 4.0, P = 0.005), while two additional studies reported no specific adverse events or described the probiotic as generally well tolerated in healthy active adults over up to 5 months. No serious adverse events were flagged across the 3 clinical studies.

Caveats: Limited evidence base (3 studies); absence of reported adverse events does not establish safety. Most studies were in healthy adults, and safety in vulnerable populations (e.g., children, pregnant women, immunocompromised individuals) has not been characterized.

Most-studied combinations with Bifidobacterium animalis subsp. lactis Bi-07

most supplement research is combination research
Also studied with:Bifidobacterium lactis Bi-07 (2), Bifidobacterium lactis BI-04 (2), Bifidobacterium animalis subsp. lactis BB-12 (3)
Back to top